 |
Magazine
Sign up for your free subscription and keep up-to-date.
Upcoming Events
Newsletters
Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.
FEBRUARY 2010
Volume 13, Issue 2
|
Fluorescence Imaging and Automated Microscopy for Cancer Management
By Calum MacAulay, Martial Guillaud and Pierre Lane
Cancer is a common, tragic and expensive disease. While more than 1/3 of the population of North American will be diagnosed with cancer at some time in their lives, and the cost of cancer in the US exceeded $219 billion in 2008(1), the situation is even worse in the developing world where even less resources are available and the human costs of cancer can be even higher. |
|
Oncology Clinical Development Challenges and Opportunites In The Phase 1 Setting
By Denise Deakin and Luc Daigneault
Cancer is a disease of the aging population. According to the Canadian Cancer Society, 43 per cent of new cancer cases and 60 per cent of deaths due to cancer occur among those who are at least 70 years old.(1) As Canadian baby boomers continue to age, the percentage of seniors in our society will increase from 13 per cent in 2005 to 23-25 per cent by the year 2031. This shift in demographics will be accompanied by a significant increase in the incidence of cancer. |
|
Chlorion Pharma Spinning Out Success
By Shawn Lawrence
A highly contested topic of late in the life sciences domain is the optimal route of commercialization for research discoveries originating in Canadian universities. |
|
New Government Initiative Promotes R&D Partnerships
By Quinn Damery
A federal government funding agency has launched a new strategy to promote increased R&D collaboration between Canadian industries and the academic sector. |
|
Energy Innovation and Commercialization on the Prairies
By Carol Reynolds
Energy, innovation and commercialization - the buzzwords are everywhere these days in government, industry and academic circles. What’s all the buzz about? |
